Supernus Pharmaceuticals : 2023 Annual Report
Dear Supernus Stockholder, We are very pleased with our performance in 2023 as we continued to successfully transition from our mature brands and set the stage to...
Source: marketscreener.com
Jacka Khattar News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jacka Khattar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jacka Khattar Today - Breaking & Trending Today
Supernus Provides Regulatory Update for SPN-830
ROCKVILLE, Md., April 08, 2024 -- Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system ...
Source: marketscreener.com
Supernus to Participate in the TD Cowen 44th Annual
ROCKVILLE, Md., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
Source: globenewswire.com
Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
ROCKVILLE, Md., Feb. 28, 2024 -- Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system ...
Source: marketscreener.com
Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
Fourth quarter 2023 net sales of Qelbree® increased 97% to $46.4 million compared to fourth quarter 2022; Full year 2023 net sales of Qelbree increased 129% to $140.2 million compared to full year...
Source: marketscreener.com